{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SEPN/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T22:45:02.684Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9889,"canonical_name":"Septerna, Inc.","cik":"0001984086","uei":null,"lei":null,"duns":null,"ticker":"SEPN"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":71,"clinical":1},"count":72,"timeline":[{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Septerna, Inc. — 2026-10-01","url_slug":"/sec/cik-0001984086/144/0001950047-26-009949","accession_number":"0001950047-26-009949","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"144","title":"144 — Septerna, Inc. — 2026-10-01","url_slug":"/sec/cik-0001984086/144/0001950047-26-009973","accession_number":"0001950047-26-009973","importance":30},{"ts":"2026-09-03","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-09-03","url_slug":"/sec/cik-0001984086/4/0001193125-26-382267","accession_number":"0001193125-26-382267","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"8-K","title":"8-K — Septerna, Inc. — 2026-08-25","url_slug":"/sec/cik-0001984086/8-k/0001193125-26-364210","accession_number":"0001193125-26-364210","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Septerna, Inc. — 2026-08-14","url_slug":"/sec/cik-0001984086/schedule-13g-a/0000938206-26-000037","accession_number":"0000938206-26-000037","importance":30},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"RA CAPITAL MANAGEMENT, L.P.","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"RA Capital Healthcare Fund LP","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"RA Capital Nexus Fund III, L.P.","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Kolchinsky Peter","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Shah Rajeev M.","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"RA CAPITAL MANAGEMENT, L.P.","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"RA Capital Healthcare Fund LP","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"RA Capital Nexus Fund III, L.P.","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Kolchinsky Peter","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Shah Rajeev M.","title":"","shares":746500,"price_per_share":42.5,"usd_value":31726250,"security_title":"Common Stock","importance":66.72625},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures V, L.P.","title":null,"shares":147059,"price_per_share":50.27,"usd_value":7392656,"security_title":"Common Stock","importance":42.392655930000004},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures GP V, LP","title":null,"shares":147059,"price_per_share":50.27,"usd_value":7392656,"security_title":"Common Stock","importance":42.392655930000004},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"TRV GP V, LLC","title":null,"shares":147059,"price_per_share":50.27,"usd_value":7392656,"security_title":"Common Stock","importance":42.392655930000004},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures VI, L.P.","title":null,"shares":147059,"price_per_share":50.27,"usd_value":7392656,"security_title":"Common Stock","importance":42.392655930000004},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures GP VI, L.P.","title":null,"shares":147059,"price_per_share":50.27,"usd_value":7392656,"security_title":"Common Stock","importance":42.392655930000004},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"TRV GP VI, LLC","title":null,"shares":147059,"price_per_share":50.27,"usd_value":7392656,"security_title":"Common Stock","importance":42.392655930000004},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures V, L.P.","title":null,"shares":141,"price_per_share":51.08,"usd_value":7202,"security_title":"Common Stock","importance":35.00720228},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures GP V, LP","title":null,"shares":141,"price_per_share":51.08,"usd_value":7202,"security_title":"Common Stock","importance":35.00720228},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"TRV GP V, LLC","title":null,"shares":141,"price_per_share":51.08,"usd_value":7202,"security_title":"Common Stock","importance":35.00720228},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures VI, L.P.","title":null,"shares":141,"price_per_share":51.08,"usd_value":7202,"security_title":"Common Stock","importance":35.00720228},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"Third Rock Ventures GP VI, L.P.","title":null,"shares":141,"price_per_share":51.08,"usd_value":7202,"security_title":"Common Stock","importance":35.00720228},{"ts":"2026-08-12","kind":"sec.insider.s","reporter":"TRV GP VI, LLC","title":null,"shares":141,"price_per_share":51.08,"usd_value":7202,"security_title":"Common Stock","importance":35.00720228},{"ts":"2026-08-11","kind":"sec.form144","reporter":"ELIZABETH P. BHATT","title":"Officer","shares":29000,"usd_value":1126650,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001950047-26-007956","importance":40.22533},{"ts":"2026-08-11","kind":"sec.insider.s","reporter":"Bhatt Elizabeth","title":"President and COO","shares":25000,"price_per_share":44,"usd_value":1100000,"security_title":"Common Stock","importance":36.1},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Bhatt Elizabeth","title":"President and COO","shares":18681,"price_per_share":6.81,"usd_value":127218,"security_title":"Common Stock","importance":15.12721761},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Bhatt Elizabeth","title":"President and COO","shares":6319,"price_per_share":2.76,"usd_value":17440,"security_title":"Common Stock","importance":15.01744044},{"ts":"2026-08-10","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Septerna, Inc. — 2026-08-10","url_slug":"/sec/cik-0001984086/10-q/0001193125-26-342353","accession_number":"0001193125-26-342353","importance":45},{"ts":"2026-08-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Septerna, Inc. — 2026-08-10","url_slug":"/sec/cik-0001984086/8-k/0001193125-26-342328","accession_number":"0001193125-26-342328","importance":35},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-08-05","url_slug":"/sec/cik-0001984086/4/0001193125-26-335820","accession_number":"0001193125-26-335820","importance":30},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":2334,"price_per_share":34.6805,"usd_value":80944,"security_title":"Common Stock","importance":35.080944287},{"ts":"2026-08-03","kind":"sec.insider.s","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":1000,"price_per_share":33.9756,"usd_value":33976,"security_title":"Common Stock","importance":35.0339756},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":1816,"price_per_share":2.76,"usd_value":5012,"security_title":"Common Stock","importance":15.00501216},{"ts":"2026-08-03","kind":"sec.insider.m","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":1518,"price_per_share":2.76,"usd_value":4190,"security_title":"Common Stock","importance":15.00418968},{"ts":"2026-07-15","kind":"sec.form144","reporter":"ELIZABETH P. BHATT","title":"Officer","shares":4000,"usd_value":138160,"security_title":"Common","approx_sale_date":"2026-07-15","accession_number":"0001950047-26-007101","importance":40.027632},{"ts":"2026-07-15","kind":"sec.insider.s","reporter":"Bhatt Elizabeth","title":"President and COO","shares":4000,"price_per_share":33.9935,"usd_value":135974,"security_title":"Common Stock","importance":35.135974},{"ts":"2026-07-15","kind":"sec.insider.m","reporter":"Bhatt Elizabeth","title":"President and COO","shares":4000,"price_per_share":6.81,"usd_value":27240,"security_title":"Common Stock","importance":15.02724},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-07-02","url_slug":"/sec/cik-0001984086/4/0001193125-26-295106","accession_number":"0001193125-26-295106","importance":30},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":2100,"price_per_share":34.0964,"usd_value":71602,"security_title":"Common Stock","importance":35.07160244},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":1233,"price_per_share":34.8141,"usd_value":42926,"security_title":"Common Stock","importance":35.0429257853},{"ts":"2026-07-01","kind":"sec.insider.m","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":3333,"price_per_share":2.76,"usd_value":9199,"security_title":"Common Stock","importance":15.00919908},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — Septerna, Inc. — 2026-06-30","url_slug":"/sec/cik-0001984086/8-k/0001193125-26-290649","accession_number":"0001193125-26-290649","importance":35},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Bassan Abraham — 2026-06-30","url_slug":"/sec/cik-0001864485/4/0001193125-26-291056","accession_number":"0001193125-26-291056","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-06-30","url_slug":"/sec/cik-0001984086/4/0001193125-26-291059","accession_number":"0001193125-26-291059","importance":30},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":2178,"price_per_share":35.18,"usd_value":76622,"security_title":"Common Stock","importance":35.07662204},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":2178,"price_per_share":6.81,"usd_value":14832,"security_title":"Common Stock","importance":15.01483218},{"ts":"2026-06-26","kind":"sec.form144","reporter":"JAE KIM","title":"Officer","shares":2438,"usd_value":89243,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006526","importance":40.017848598},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-06-24","url_slug":"/sec/cik-0001984086/4/0001193125-26-281461","accession_number":"0001193125-26-281461","importance":30},{"ts":"2026-06-22","kind":"sec.form144","reporter":"JAE KIM","title":"Officer","shares":94339,"usd_value":3326120,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006351","importance":40.665223912},{"ts":"2026-06-22","kind":"sec.form144","reporter":"DANIEL LONG","title":"Officer","shares":25000,"usd_value":904250,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006361","importance":40.18085},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":8000,"price_per_share":35.1001,"usd_value":280801,"security_title":"Common Stock","importance":35.2808008},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":7000,"price_per_share":35.9687,"usd_value":251781,"security_title":"Common Stock","importance":35.2517809},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — Septerna, Inc. — 2026-06-22","url_slug":"/sec/cik-0001984086/144/0001950047-26-006361","accession_number":"0001950047-26-006361","importance":30},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":4471,"price_per_share":11.7,"usd_value":52311,"security_title":"Common Stock","importance":15.0523107},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Long Daniel D.","title":"SVP, Drug Discovery","shares":10529,"price_per_share":2.76,"usd_value":29060,"security_title":"Common Stock","importance":15.02906004},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-06-16","url_slug":"/sec/cik-0001984086/4/0001193125-26-273126","accession_number":"0001193125-26-273126","importance":30},{"ts":"2026-06-12","kind":"sec.form144","reporter":"SAMIRA SHAIKHLY","title":"Officer","shares":8428,"usd_value":286805,"security_title":"Common","approx_sale_date":"2026-06-12","accession_number":"0001950047-26-006015","importance":40.057360968},{"ts":"2026-06-12","kind":"sec.insider.s","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":6250,"price_per_share":35.0759,"usd_value":219224,"security_title":"Common Stock","importance":35.219224375},{"ts":"2026-06-12","kind":"sec.filing","form_type":"144","title":"144 — Septerna, Inc. — 2026-06-12","url_slug":"/sec/cik-0001984086/144/0001950047-26-006015","accession_number":"0001950047-26-006015","importance":30},{"ts":"2026-06-12","kind":"sec.insider.m","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":6250,"price_per_share":11.7,"usd_value":73125,"security_title":"Common Stock","importance":15.073125},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Septerna, Inc. — 2026-06-03","url_slug":"/sec/cik-0001984086/4/0001193125-26-255997","accession_number":"0001193125-26-255997","importance":30},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":2889,"price_per_share":29.6629,"usd_value":85696,"security_title":"Common Stock","importance":35.0856961181},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":1700,"price_per_share":27.7831,"usd_value":47231,"security_title":"Common Stock","importance":35.04723127},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":1346,"price_per_share":28.7928,"usd_value":38755,"security_title":"Common Stock","importance":35.0387551088},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":4355,"price_per_share":1.55,"usd_value":6750,"security_title":"Common Stock","importance":15.00675025},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":943,"price_per_share":2.76,"usd_value":2603,"security_title":"Common Stock","importance":15.00260268},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Shaikhly Samira","title":"Chief People Officer","shares":637,"price_per_share":2.76,"usd_value":1758,"security_title":"Common Stock","importance":15.00175812},{"ts":"2026-04-22","kind":"clinical.trial","reporter":"Septerna, Inc.","title":"A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT07433179","excerpt":"[\"Healthy Volunteers\"]","importance":30}]}